RANDAL J KIRK Insider Trading $HSGX Ocugen, Inc.
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).
RANDAL J KIRK in Ocugen, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner
Holdings: 2,438,770 shares
Current Value: $4,048,358
Latest Transaction: Jan 15 2019
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RANDAL J KIRK in Ocugen, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15 2019 | HSGX | HISTOGENICS CORP | KIRK RANDAL J | 10% Owner | Sell | S | 0.15 | 345,897 | 51,885 | 1,692,366 | 2 M to 1.7 M (-16.97 %) |
| Jan 15 2019 | HSGX | HISTOGENICS CORP | KIRK RANDAL J | 10% Owner | Sell | S | 0.16 | 400,507 | 64,081 | 2,038,263 | 2.4 M to 2 M (-16.42 %) |
| Jan 15 2019 | HSGX | HISTOGENICS CORP | KIRK RANDAL J | 10% Owner | Sell | S | 0.17 | 251,800 | 42,806 | 2,438,770 | 2.7 M to 2.4 M (-9.36 %) |
Page: 1